Zach Winn

3 days ago | idm.net.au | Zach Winn

Data should drive every decision a modern business makes. But most businesses have a massive blind spot: They don’t know what’s happening in their visual data. Coactive is working to change that. The company, founded by Cody Coleman ’13, MEng ’15 and William Gaviria Rojas ’13, has created an artificial intelligence-powered platform that can make sense of data like images, audio, and video to unlock new insights.

4 days ago | news.mit.edu | Zach Winn

Modern fighter jets contain hundreds or even thousands of sensors. Some of those sensors collect data every second, others every nanosecond. For the engineering teams building and testing those jets, all those data points are hugely valuable — if they can make sense of them. Nominal is an advanced software platform made for engineers building complex systems ranging from fighter jets to nuclear reactors, satellites, rockets, and robots.

5 days ago | homelandsecuritynewswire.com | Zach Winn

INNOVATIONMIx Helps Innovators Tackle Challenges in National SecurityPublished 24 June 2025Startups and government defense agencies have historically seemed like polar opposites. Startups thrive on speed and risk, while defense agencies are more cautious. Mission Innovation x creates education and research opportunities while facilitating connections between defense agencies and MIT innovators. Startups and government defense agencies have historically seemed like polar opposites.

5 days ago | news.mit.edu | Zach Winn

Startups and government defense agencies have historically seemed like polar opposites. Startups thrive on speed and risk, while defense agencies are more cautious. Over the past few years, however, things have changed. Many startups are eager to work with these organizations, which are always looking for innovative solutions to their hardest problems.

2 weeks ago | news.mit.edu | Zach Winn

In the biotech and pharmaceutical industries, ELISA tests provide critical quality control during drug development and manufacturing. The tests can precisely quantify protein levels, but they also require hours of work by trained technicians and specialized equipment. That makes them prohibitively expensive, driving up the costs of drugs and putting research testing out of reach for many.